{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:01:18Z","timestamp":1793325678363,"version":"4.5.0"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008884","name":"Edward P. Evans Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.leukres.2023.107038","type":"journal-article","created":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T10:46:03Z","timestamp":1676112363000},"page":"107038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers"],"prefix":"10.1016","volume":"127","author":[{"given":"Carmelo","family":"Gurnari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Visconte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6485","key":"10.1016\/j.leukres.2023.107038_bib1","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.aay9333","article-title":"The evolutionary dynamics and fitness landscape of clonal hematopoiesis","volume":"367","author":"Watson","year":"2020","journal-title":"Science"},{"issue":"26","key":"10.1016\/j.leukres.2023.107038_bib2","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.leukres.2023.107038_bib3","doi-asserted-by":"crossref","first-page":"12484","DOI":"10.1038\/ncomms12484","article-title":"Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults","volume":"7","author":"Young","year":"2016","journal-title":"Nat. Commun."},{"issue":"5405","key":"10.1016\/j.leukres.2023.107038_bib4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2023.107038_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.exphem.2020.01.008","article-title":"60 Years of clonal hematopoiesis research: From X-chromosome inactivation studies to the identification of driver mutations","volume":"83","author":"Ayachi","year":"2020","journal-title":"Exp. Hematol."},{"issue":"26","key":"10.1016\/j.leukres.2023.107038_bib6","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N. Engl. J. Med"},{"issue":"2","key":"10.1016\/j.leukres.2023.107038_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N. Engl. J. Med"},{"issue":"3","key":"10.1016\/j.leukres.2023.107038_bib8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCRESAHA.117.312115","article-title":"Somatic mutations and clonal hematopoiesis: unexpected potential new drivers of age-related cardiovascular disease","volume":"122","author":"Fuster","year":"2018","journal-title":"Circ. Res"},{"issue":"7913","key":"10.1016\/j.leukres.2023.107038_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41586-022-04786-y","article-title":"Clonal dynamics of haematopoiesis across the human lifespan","volume":"606","author":"Mitchell","year":"2022","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.leukres.2023.107038_bib10","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41591-018-0081-z","article-title":"Somatic mutations precede acute myeloid leukemia years before diagnosis","volume":"24","author":"Desai","year":"2018","journal-title":"Nat. Med"},{"issue":"11","key":"10.1016\/j.leukres.2023.107038_bib11","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood.2021011323","article-title":"Relationship between clone metrics and clinical outcome in clonal cytopenia","volume":"138","author":"Galli","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2023.107038_bib12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.seminhematol.2022.08.002","article-title":"Clinical manifestations of clonal hematopoiesis: what has SF3B1-mutant MDS taught us?","volume":"59","author":"Todisco","year":"2022","journal-title":"Semin Hematol."},{"issue":"3","key":"10.1016\/j.leukres.2023.107038_bib13","first-page":"294","article-title":"Who really discovered aplastic anemia?","volume":"80","author":"Marmont","year":"1995","journal-title":"Haematol."},{"key":"10.1016\/j.leukres.2023.107038_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1182\/blood.V30.2.251.251","article-title":"Riddle: what do aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH) and \"hypoplastic\" leukemia have in common?","author":"Dameshek","year":"1967","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.leukres.2023.107038_bib15","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJM199511093331904","article-title":"Natural history of paroxysmal nocturnal hemoglobinuria","volume":"333","author":"Hillmen","year":"1995","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.1016\/j.leukres.2023.107038_bib16","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1182\/blood-2005-06-2485","article-title":"Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia","volume":"107","author":"Sugimori","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2023.107038_bib17","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/bjh.12661","article-title":"Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study","volume":"164","author":"Kulagin","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.leukres.2023.107038_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1182\/blood.2019000940","article-title":"Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria","volume":"136","author":"Sun","year":"2020","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.leukres.2023.107038_bib19","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1182\/blood-2017-02-767731","article-title":"Origins of myelodysplastic syndromes after aplastic anemia","volume":"130","author":"Negoro","year":"2017","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.leukres.2023.107038_bib20","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/blood-2012-05-432906","article-title":"Interferon-gamma impairs proliferation of hematopoietic stem cells in mice","volume":"121","author":"de Bruin","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2023.107038_bib21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.seminhematol.2013.03.028","article-title":"Aplastic anemia: what have we learned from animal models and from the clinic","volume":"50","author":"Scheinberg","year":"2013","journal-title":"Semin Hematol."},{"issue":"9","key":"10.1016\/j.leukres.2023.107038_bib22","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood-2011-08-368308","article-title":"Functional characterization of CD4+ T cells in aplastic anemia","volume":"119","author":"Kordasti","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2023.107038_bib23","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1182\/blood-2007-01-066258","article-title":"Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia","volume":"110","author":"Solomou","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2023.107038_bib24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.7326\/0003-4819-126-2-199701150-00004","article-title":"Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia","volume":"126","author":"Hinterberger","year":"1997","journal-title":"Ann. Intern Med"},{"issue":"9","key":"10.1016\/j.leukres.2023.107038_bib25","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1182\/blood.V93.9.3008.409a10_3008_3016","article-title":"Characterization of T-cell repertoire of the bone marrow in immune-mediated aplastic anemia: evidence for the involvement of antigen-driven T-cell response in cyclosporine-dependent aplastic anemia","volume":"93","author":"Zeng","year":"1999","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2023.107038_bib26","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1182\/blood-2005-09-3902","article-title":"Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome","volume":"108","author":"Wlodarski","year":"2006","journal-title":"Blood"},{"issue":"9431","key":"10.1016\/j.leukres.2023.107038_bib27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(04)16724-X","article-title":"In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing","volume":"364","author":"Risitano","year":"2004","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.leukres.2023.107038_bib28","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1182\/blood-2013-04-494930","article-title":"STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients","volume":"122","author":"Jerez","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2023.107038_bib29","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s00277-005-1022-8","article-title":"Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia","volume":"84","author":"Dubey","year":"2005","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2023.107038_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-8674(00)81850-4","article-title":"Somatic mutations in paroxysmal nocturnal hemoglobinuria: a blessing in disguise","volume":"88","author":"Luzzatto","year":"1997","journal-title":"Cell"},{"issue":"47","key":"10.1016\/j.leukres.2023.107038_bib31","doi-asserted-by":"crossref","first-page":"18496","DOI":"10.1073\/pnas.0802749105","article-title":"Neutral evolution in paroxysmal nocturnal hemoglobinuria","volume":"105","author":"Dingli","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.leukres.2023.107038_bib32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1600-0609.2011.01615.x","article-title":"Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia","volume":"87","author":"Pu","year":"2011","journal-title":"Eur. J. Haematol."},{"issue":"12","key":"10.1016\/j.leukres.2023.107038_bib33","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1182\/blood-2002-03-0799","article-title":"Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome","volume":"100","author":"Wang","year":"2002","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.leukres.2023.107038_bib34","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.1182\/blood-2010-11-314393","article-title":"SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes","volume":"117","author":"Afable","year":"2011","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.leukres.2023.107038_bib35","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1182\/blood-2016-11-752378","article-title":"Identification of an HLA class I allele closely involved in the autoantigen presentation in acquired aplastic anemia","volume":"129","author":"Zaimoku","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2023.107038_bib36","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3324\/haematol.2020.247809","article-title":"A frequent nonsense mutation in exon 1 across certain HLA-A and -B alleles in leukocytes of patients with acquired aplastic anemia","volume":"106","author":"Mizumaki","year":"2021","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.leukres.2023.107038_bib37","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1172\/JCI11002","article-title":"Genetic and environmental effects in paroxysmal nocturnal hemoglobinuria: this little PIG-A goes \"Why? Why? Why?\"","volume":"106","author":"Young","year":"2000","journal-title":"J. Clin. Invest"},{"issue":"2","key":"10.1016\/j.leukres.2023.107038_bib38","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/leu.2010.274","article-title":"Deletions of Xp22.2 including PIG-A locus lead to paroxysmal nocturnal hemoglobinuria","volume":"25","author":"O'Keefe","year":"2011","journal-title":"Leukemia"},{"issue":"14","key":"10.1016\/j.leukres.2023.107038_bib39","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood-2012-11-469353","article-title":"Glycosylphosphatidylinositol-specific, CD1d-restricted T cells in paroxysmal nocturnal hemoglobinuria","volume":"121","author":"Gargiulo","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2023.107038_bib40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1053\/j.seminhematol.2021.12.001","article-title":"Aplastic anemia: Quo vadis?","volume":"59","author":"Gurnari","year":"2022","journal-title":"Semin Hematol."},{"issue":"Suppl 2","key":"10.1016\/j.leukres.2023.107038_bib41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/BF03165111","article-title":"The relationship of aplastic anemia and PNH","volume":"76","author":"Young","year":"2002","journal-title":"Int J. Hematol."},{"issue":"11","key":"10.1016\/j.leukres.2023.107038_bib42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41408-021-00582-5","article-title":"Is nature truly healing itself? Spontaneous remissions in Paroxysmal Nocturnal Hemoglobinuria","volume":"11","author":"Gurnari","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.leukres.2023.107038_bib43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.iy.12.040194.002005","article-title":"Tumor antigens recognized by T lymphocytes","volume":"12","author":"Boon","year":"1994","journal-title":"Annu Rev. Immunol."},{"issue":"7","key":"10.1016\/j.leukres.2023.107038_bib44","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.trecan.2020.02.022","article-title":"Turning cold into hot: firing up the tumor microenvironment","volume":"6","author":"Duan","year":"2020","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.leukres.2023.107038_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<91::AID-IJC17>3.0.CO;2-4","article-title":"Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors","volume":"83","author":"Jimenez","year":"1999","journal-title":"Int J. Cancer"},{"issue":"11","key":"10.1016\/j.leukres.2023.107038_bib46","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.humimm.2005.10.011","article-title":"Frequent HLA class I loss is an early event in cervical carcinogenesis","volume":"66","author":"Vermeulen","year":"2005","journal-title":"Hum. Immunol."},{"issue":"7","key":"10.1016\/j.leukres.2023.107038_bib47","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00251-006-0111-8","article-title":"LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas","volume":"58","author":"Maleno","year":"2006","journal-title":"Immunogenetics"},{"issue":"1","key":"10.1016\/j.leukres.2023.107038_bib48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2141.2004.05151.x","article-title":"Loss of heterozygosity, a frequent but a non-exclusive mechanism responsible for HLA dysregulation in non-Hodgkin's lymphomas","volume":"127","author":"Drenou","year":"2004","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.leukres.2023.107038_bib49","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1399-0039.2004.00324.x","article-title":"Loss of heterozygosity in the HLA class I region in human pancreatic cancer","volume":"64","author":"Ryschich","year":"2004","journal-title":"Tissue Antigens"},{"issue":"11","key":"10.1016\/j.leukres.2023.107038_bib50","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nbt.3344","article-title":"Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes","volume":"33","author":"Shukla","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.leukres.2023.107038_bib51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.seminhematol.2021.12.003","article-title":"Clonal dynamics of hematopoietic stem cell compartment in aplastic anemia","volume":"59","author":"Visconte","year":"2022","journal-title":"Semin Hematol."},{"key":"10.1016\/j.leukres.2023.107038_bib52","article-title":"Molecular landscape of immune pressure and escape in aplastic anemia","author":"Pagliuca","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2023.107038_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.944872","article-title":"Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond","volume":"13","author":"Pagliuca","year":"2022","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.leukres.2023.107038_bib54","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1414799","article-title":"Somatic mutations and clonal hematopoiesis in aplastic anemia","volume":"373","author":"Yoshizato","year":"2015","journal-title":"N. Engl. J. Med"},{"issue":"17","key":"10.1016\/j.leukres.2023.107038_bib55","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1182\/blood-2014-05-574889","article-title":"Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome","volume":"124","author":"Kulasekararaj","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2023.107038_bib56","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/leu.2013.30","article-title":"Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia","volume":"27","author":"Lane","year":"2013","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.leukres.2023.107038_bib57","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cancergen.2015.01.007","article-title":"Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia","volume":"208","author":"Babushok","year":"2015","journal-title":"Cancer Genet"},{"issue":"9","key":"10.1016\/j.leukres.2023.107038_bib58","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.3324\/haematol.2013.101642","article-title":"Genetic characterization of acquired aplastic anemia by targeted sequencing","volume":"99","author":"Heuser","year":"2014","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.leukres.2023.107038_bib59","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.3324\/haematol.2014.120931","article-title":"Mutations of ASXL1 and TET2 in aplastic anemia","volume":"100","author":"Huang","year":"2015","journal-title":"Haematologica"},{"issue":"22","key":"10.1016\/j.leukres.2023.107038_bib60","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1182\/bloodadvances.2017010918","article-title":"Somatic HLA mutations expose the role of class I-mediated autoimmunity in aplastic anemia and its clonal complications","volume":"1","author":"Babushok","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.leukres.2023.107038_bib61","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/nyas.12235","article-title":"In Darwinian evolution, feedback from natural selection leads to biased mutations","volume":"1305","author":"Caporale","year":"2013","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"6","key":"10.1016\/j.leukres.2023.107038_bib62","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1182\/blood.V79.6.1385.1385","article-title":"The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated","volume":"79","author":"Young","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107038_bib63","article-title":"Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria","author":"Gurnari","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.leukres.2023.107038_bib64","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.3324\/haematol.2018.206540","article-title":"Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study","volume":"104","author":"Rogers","year":"2019","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.leukres.2023.107038_bib65","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood.V99.9.3129","article-title":"Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia","volume":"99","author":"Maciejewski","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2023.107038_bib66","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/bjh.14510","article-title":"Recent advances in understanding clonal haematopoiesis in aplastic anaemia","volume":"177","author":"Stanley","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.leukres.2023.107038_bib67","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1056\/NEJMoa0811036","article-title":"Loss of mismatched HLA in leukemia after stem-cell transplantation","volume":"361","author":"Vago","year":"2009","journal-title":"N. Engl. J. Med"},{"issue":"12","key":"10.1016\/j.leukres.2023.107038_bib68","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/gm396","article-title":"Derivation of HLA types from shotgun sequence datasets","volume":"4","author":"Warren","year":"2012","journal-title":"Genome Med"},{"key":"10.1016\/j.leukres.2023.107038_bib69","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163040","article-title":"Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities","author":"Olson","year":"2022","journal-title":"JCI Insight"},{"issue":"26","key":"10.1016\/j.leukres.2023.107038_bib70","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1182\/blood.2021012900","article-title":"The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disorders","volume":"138","author":"Pagliuca","year":"2021","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2023.107038_bib71","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.exphem.2016.05.013","article-title":"Clinical significance and origin of leukocytes that lack HLA-A allele expression in patients with acquired aplastic anemia","volume":"44","author":"Maruyama","year":"2016","journal-title":"Exp. Hematol."},{"issue":"9","key":"10.1016\/j.leukres.2023.107038_bib72","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/molbev\/msy116","article-title":"Divergent Allele Advantage at Human MHC Genes: Signatures of Past and Ongoing Selection","volume":"35","author":"Pierini","year":"2018","journal-title":"Mol. Biol. Evol."},{"issue":"8","key":"10.1016\/j.leukres.2023.107038_bib73","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","article-title":"Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1beta\/NLRP3 inflammasome","volume":"71","author":"Sano","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.leukres.2023.107038_bib74","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1182\/blood.2021013531","article-title":"Association of clonal hematopoiesis with chronic obstructive pulmonary disease","volume":"139","author":"Miller","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107038_bib75","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.20201544","article-title":"Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS","volume":"218","author":"Trowbridge","year":"2021","journal-title":"J. Exp. Med"},{"issue":"5","key":"10.1016\/j.leukres.2023.107038_bib76","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41590-020-0663-z","article-title":"Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCs","volume":"21","author":"Muto","year":"2020","journal-title":"Nat. Immunol."},{"issue":"27","key":"10.1016\/j.leukres.2023.107038_bib77","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and\u00a0severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.leukres.2023.107038_bib78","article-title":"An update on VEXAS syndrome","author":"Al-Hakim","year":"2022","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"8","key":"10.1016\/j.leukres.2023.107038_bib79","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41584-022-00778-4","article-title":"Disorders of ubiquitylation: unchained inflammation","volume":"18","author":"Beck","year":"2022","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.leukres.2023.107038_bib80","doi-asserted-by":"crossref","unstructured":"Kosmider O, P.C., Templ\u00e9 M., Corneau A., Carbone F., Duroyon E., Chirayath T.-W., Luka M., Gobeaux C., Lazaro E., Outh R., Le Guenno G., Lifermann F., Berleur M., Friedrich C., Lenormand C., Weitten T., Guillotin V., Burroni B., Sohier P., Boussier J., Willems L., Aractingi S., Dionet L., Tharaux P.-L., Vergier B., Raynaud P., Ea H.-K., M\u00e9nager M., Duffy D., Terrier B..VEXAS syndrome is characterized by blood and tissues inflammasome pathway activation and monocyte dysregulation.medRxiv.orh 2022; https:\/\/doi.org\/10.1101\/2022.10.12.22281005.","DOI":"10.1101\/2022.10.12.22281005"},{"issue":"8","key":"10.1016\/j.leukres.2023.107038_bib81","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/blood.2022016642","article-title":"Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study","volume":"140","author":"Heiblig","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2023.107038_bib82","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/bjh.17679","article-title":"Vacuoles in neutrophil precursors in VEXAS syndrome: diagnostic performances and threshold","volume":"195","author":"Lacombe","year":"2021","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.leukres.2023.107038_bib83","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ng.3726","article-title":"Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias","volume":"49","author":"Dunford","year":"2017","journal-title":"Nat. Genet"},{"issue":"10","key":"10.1016\/j.leukres.2023.107038_bib84","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000775","article-title":"UBA1 screening in sweet syndrome with hematological neoplasms reveals a novel association between VEXAS and chronic myelomonocytic leukemia","volume":"6","author":"Gurnari","year":"2022","journal-title":"Hemasphere"},{"issue":"26","key":"10.1016\/j.leukres.2023.107038_bib85","first-page":"3591","article-title":"VEXAS syndrome","volume":"137","author":"Grayson","year":"2021","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.leukres.2023.107038_bib86","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1182\/blood.2021010811","article-title":"Vacuolization of hematopoietic precursors: an enigma with multiple etiologies","volume":"137","author":"Gurnari","year":"2021","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2023.107038_bib87","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood-2016-02-700054","article-title":"Time-dependent changes in mortality and transformation risk in MDS","volume":"128","author":"Pfeilstocker","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2023.107038_bib88","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/bjd.20805","article-title":"Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients","volume":"186","author":"Georgin-Lavialle","year":"2022","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.leukres.2023.107038_bib89","first-page":"134","article-title":"UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review","volume":"6","author":"Shaukat","year":"2022","journal-title":"Mod\u2009Rheuma Case Rep."},{"issue":"10","key":"10.1016\/j.leukres.2023.107038_bib90","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1182\/blood.2022015384","article-title":"TET2-mutant clonal hematopoiesis and risk of gout","volume":"140","author":"Agrawal","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107038_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/s41409-022-01774-8","article-title":"Update on VEXAS and role of allogeneic bone marrow transplant: considerations on behalf of the chronic malignancies working party of the EBMT","author":"Gurnari","year":"2022","journal-title":"Bone Marrow Transpl."},{"issue":"11","key":"10.1016\/j.leukres.2023.107038_bib92","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1038\/s41375-022-01698-8","article-title":"A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune\/inflammatory disorders and VEXAS syndrome associated with MDS and CMML","volume":"36","author":"Mekinian","year":"2022","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.leukres.2023.107038_bib93","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/bjh.17893","article-title":"Azacitidine for patients with vacuoles, E1 Enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry","volume":"196","author":"Comont","year":"2022","journal-title":"Br. J. Haematol."},{"issue":"12","key":"10.1016\/j.leukres.2023.107038_bib94","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000661","article-title":"Azacytidine treatment for VEXAS syndrome","volume":"5","author":"Raaijmakers","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.leukres.2023.107038_bib95","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keac371","article-title":"Influence of HLA polymorphisms on clinical features of VEXAS syndrome: a potential epistatic mechanism","author":"Lucchino","year":"2022","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.leukres.2023.107038_bib96","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.yjmcc.2021.07.004","article-title":"Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease","volume":"161","author":"Marnell","year":"2021","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.leukres.2023.107038_bib97","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.exphem.2019.11.008","article-title":"Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients","volume":"80","author":"Zhang","year":"2019","journal-title":"Exp. Hematol."},{"issue":"6","key":"10.1016\/j.leukres.2023.107038_bib98","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.stem.2018.10.013","article-title":"Inhibition of inflammatory signaling in Tet2 mutant preleukemic cells mitigates stress-induced abnormalities and clonal hematopoiesis","volume":"23","author":"Cai","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.leukres.2023.107038_bib99","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/j.seminhematol.2021.10.004","article-title":"Clonal hematopoiesis and VEXAS syndrome: survival of the fittest clones?","volume":"58","author":"Kusne","year":"2021","journal-title":"Semin Hematol."},{"issue":"Supplement 1","key":"10.1016\/j.leukres.2023.107038_bib100","first-page":"5745","article-title":"Clonal hematopoiesis in Vexas Syndrome.Blood","volume":"140","author":"Patel BA","year":"2022"},{"issue":"10","key":"10.1016\/j.leukres.2023.107038_bib101","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/s41588-022-01179-9","article-title":"Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation","volume":"54","author":"Nam","year":"2022","journal-title":"Nat. Genet"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623000231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623000231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:03:54Z","timestamp":1758935034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212623000231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":101,"alternative-id":["S0145212623000231"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107038","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107038"}}